PAVM (31) RVP (33) CTSO (21) PMI (61) ⌘ Pro Terminal →

Modular Medical Inc. (MODD) — RQD Stock Rating Cockpit

$1.72 -9.95% NASDAQ • Live Quote vs Prior Daily Close (Synced Snapshot)

Modular Medical Inc. (MODD) carries a Roarable Rating of D- (Sell) with 36/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE D- • RED ALERT Cap $16.3M

📤 Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card

INTERACTIVE SCENARIO DECK:

🛡️ Portfolio Crash X-Ray

RQD QUANT TACHOMETERRED ALERT • D-

3-of-3 JEV AI Jury Bearish Warning

Cash

SEC

Whale

Impersonal quantitative research (0–100 RQD rubric) — not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E · Rk D

Each axis scored 0–20

12M PRICE TARGET CONE-9.9% Base Target

WHALE OPTIONS SNAPSHOT: — (No Active Options Snapshot on file for MODD)Realized 20D OHLCV Swing Band: ±12.5%

RSI-14 MOMENTUMNEUTRAL RANGE

39.230 Oversold · 70 Hot

ALTMAN-Z SHIELDFORTRESS SAFE (>3.0)

3.80>3.0 Fortress Safe

PIOTROSKI F-SCOREWEAK QUALITY (1–4)

2 / 99-Pt Accounting

52-WEEK LASER RANGE2% OF RANGE

L: $2$1.72H: $19

1. Money & Cash Health● WEAK

Are profits real cash in the bank?

Weak cash conversion or heavy valuation strain compared to actual cash earned.

Factor Grade: D-RQD 7 / 20

2. Big Money & Insiders● TRIMMING

Are whales & executives buying or selling?

Insiders and big institutional desks have been trimming shares rather than stepping up to buy.

Factor Grade: ERQD 9 / 40

3. Hidden Risks & Market Weather● WARNING

SEC fine-print scan & interest-rate fit

High sensitivity to tight interest rates or new risk warnings added to recent SEC annual filings.

Factor Grade: DRQD 20 / 40

MULTI-MODEL JEV QUANT JURY DELIBERATION

3-of-3 JEV AI Jury Bearish Warning on MODD

Cash & Moat Bull AI

ROIC & Free Cash Flow Model

BEARISH (35)

-35.0% ROIC with 42.0% gross margin and 2.80% FCF yield.

SEC Forensic Auditor AI

10-K Accruals & Altman-Z Guard

BEARISH (50)

Altman-Z 4.20 and Piotroski 2/9 pass balance-sheet audit.

Whale & Macro Hawk AI

Options Skew, 13F & Fed NetLiq

BEARISH (32)

9/40 institutional & smart-money positioning score with 10/20 macro alignment.

Bull Case: Why Buyers Like MODD

✓Established market leader in Health Care with deep daily trading liquidity.

Bear Case: What Could Go Wrong

!Company executives have done more routine share selling than personal cash buying lately.
!Sensitive to high interest rates and tighter Federal Reserve market liquidity.
!Recent SEC filings added new risk-factor disclosures that warrant keeping an eye on margins.

ON-DEMAND RQD QUANT WORKSHOP • SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring MODD)

✓Walkthrough of MODD's RQD Radar, SEC cash-conversion gap & downside invalidation levels
✓3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
✓Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks

RQD INSIDER CLUB WAITLIST$49/YR PLANNED

Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?

Join Founding VIP Waitlist (No Card Required) →$100K Arena

MODD // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -60.37%🛡️ HOLDING TREND SUPPORT

2026-10-30O $1.73H $1.80L $1.72C $1.72VOL 20.6K

RES: $2.49SUP: $1.51SMA50: $2.51SMA200: $5.25

PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

MODD Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

🦋 MODD Butterfly Map → + Track MODD →

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)

8.0%/yr Implied 5Y Growth

vs. +6.0% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on MODD today. View full Setup Ledger →

🦋 Documented & Second-Order Butterfly Connections Open Graph →

No direct multi-tier Butterfly edges indexed yet for MODD. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video

🎬 No recent verified company-specific video clip queued for MODD today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk →

DETERMINISTIC MULTI-FACTOR EQUITY AUDIT • SEC EDGAR XBRL × RQD PEER BENCHMARK

📊 Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (MODD)

Health Care Rank #799 of 1016 ⚔️ PAVM vs MODD Full Matrix →

1. Head-to-Head Health Care Peer Comparison (MODD vs. PAVM, RVP, CTSO, PMI)

Industry: Medical/Dental Instruments (120 Tracked Issuers)

Across 1016 tracked Health Care securities in the Roarable RQD universe, Modular Medical Inc. (MODD) ranks #799 by composite RQD confidence (36/100, grade D-) and #850 by equity capitalization ($16.3M). Within this direct 5-issuer industry benchmark cohort, MODD leads on earnings valuation at N/A trailing P/E, while RVP leads on capital efficiency and profitability with -23.3% ROIC and 0.1% gross margin. PMI currently holds the highest overall quantitative score in the immediate peer group at 61/100 (C-) compared with MODD at 36/100 (D-).

Ticker / Company	Roarable Grade	RQD Score	Trailing P/E	Gross Margin	ROIC	1D Change	Market Cap	Head-to-Head
MODD ACTIVE Modular Medical Inc.	D-	36/100	—	—	-35.0%	-9.95%	$16.3M	Benchmark Subject
PAVM PAVmed Inc.	E	31/100	—	-30.0%	-35.0%	-5.29%	$15.8M	/pavm-vs-modd →
RVP Retractable Technologies Inc.	E	33/100	—	0.1%	-23.3%	-1.15%	$17.3M	/rvp-vs-modd →
CTSO Cytosorbents Corporation	E	21/100	—	71.5%	-35.0%	-16.03%	$13.9M	/ctso-vs-modd →
PMI Picard Medical Inc.	C-	61/100	—	—	—	+12.17%	$19.9M	/pmi-vs-modd →

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K • FILED 2026-03-31 • CIK 0001074871

In its most recent audited fiscal period (FY2025, filed 2026-03-31), Modular Medical Inc. (MODD) reported GAAP revenue of $0 (N/A vs. FY2024 revenue of $0 ) , GAAP net income of -$28.2M, operating cash flow of -$23.8M, and free cash flow of -$27.7M (-52.0% YoY). On the balance sheet, MODD closed FY2025 with $10.3M in total assets against $0 in total debt (Altman Z-Score: N/A, Piotroski F-Score: 2/9).

Fiscal Period	Filing Date	Revenue	Net Income	Operating Cash Flow	Free Cash Flow	Total Assets	Total Debt
FY2025 (FY)	2026-03-31	$0	-$28.2M	-$23.8M	-$27.7M	$10.3M	—
FY2024 (FY)	2025-03-31	$0	-$18.8M	-$15.7M	-$18.2M	$12.1M	—
FY2023 (FY)	2024-03-31	$0	-$17.5M	-$14.0M	-$14.0M	—	—

3. MODD Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

✓ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is MODD stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-01, Modular Medical Inc. (NASDAQ: MODD) is rated D- (Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 36/100 at a spot price of $1.72 (-9.95% 1D, market cap $16.3M). Pillar breakdown: Fundamental Cash Engine 7/20, Institutional 13F & Options Flow 4/20, Executive Insider Alignment 10/20, FRED Macro Regime Fit 10/20, and SEC Balance-Sheet Forensics 5/20. Across 1016 tracked Health Care issuers, MODD ranks #799 in composite RQD confidence.

How does MODD compare to PAVM and RVP in the Health Care sector?

Within the Health Care sector (Medical/Dental Instruments), MODD carries a Roarable D- (36/100 RQD), trailing P/E of N/A, gross margin of —, and ROIC of -35.0%. By comparison, PAVM (PAVmed Inc.) holds a E grade (31/100 RQD, P/E N/A, ROIC -35.0%, cap $15.8M) and RVP (Retractable Technologies Inc.) posts a E grade (33/100 RQD, P/E N/A, ROIC -23.3%, cap $17.3M). Among the 5-stock peer group, MODD leads on earnings multiple (N/A) while RVP leads on capital efficiency (-23.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for MODD?

Per MODD's SEC EDGAR XBRL 10-K filing (FY2025, filed 2026-03-31, CIK 0001074871), Modular Medical Inc. generated $0 in revenue, -$28.2M in net income, and -$27.7M in free cash flow against $10.3M in total assets and $0 in total debt. Key quantitative strengths: Established market leader in Health Care with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is MODD trading relative to its 50-day, 200-day, and 52-week technical levels?

MODD last traded at $1.72 (-9.95% on volume of 17,025 shares), positioning the stock -31.47% below its 50-day simple moving average ($2.51) and -67.24% below its 200-day simple moving average ($5.25). Across its 52-week range of $1.52 to $18.66, MODD sits at the 1.2% percentile with a 14-day RSI of 39.2 (NEUTRAL RANGE) and an implied next-earnings move of ±12.5% ($1.51 to $1.93).

MODD Investor FAQ & Complete 8-Part Research Index

100% OPEN ACCESS • SEC EDGAR × CBOE × FRED

Should I buy, hold, or sell MODD stock right now?

Modular Medical Inc. (MODD) currently earns a Roarable Rating of D- (Sell — SELL) with 36/100 RQD Confidence. Stretched risk/reward at current multiples (-35% return on capital) under elevated 10-year interest-rate pressure.

What is MODD's 12-month price target and RQD AI Jury consensus?

MODD's 12-month base price target is $1.55 (range $1.21 to $19.59), backed by transparent SEC XBRL cash-flow, Form 4 insider, and CBOE options flow analysis.

Direct Sub-Reports: MODD RQD Cockpit MODD 12M Forecast MODD Earnings & Move MODD Dividends & DRIP MODD Insiders & 13F MODD Whale Options MODD Profit Sankey MODD News & Why